Sperzel John J III
- SEC CIK
- 0001602618
No open-market purchases or sales filed in the past year.
Current role at each company
- TTOO T2 Biosystems, Inc.See Remarksas of Jan 2, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Sperzel John J III as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 9, 2023 (view filing) | Feb 22-28 | 15 daysLate | Sperzel John J IIIChairman and CEO | SSale | −9.77K | $0.6322 | −$6.18K | −36.1%17.3K after | 2 lots |
| Apr 11, 2022 (view filing) | Apr 7 | 4 days | Sperzel John J IIIChairman, CEO, and President | PPurchase | +30.0K | $0.50 | +$15.0K | +15.6%221.8K after |